The effect of vit D supplement on ejection fraction, ferritin and hypertention in beta-thalassaemia major patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016022110222N5

Enrollment

Registered

2016-03-04

Start date

2016-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cooley anemia. Beta thalassaemia

Interventions

Patients with thalassemia major with iron overload or precipitate heart they do have mild, measured levels of vitamin D, ferritin and blood pressure measurement is performed. Vit D level of 74 nmol be

Early detection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with thalassemia major with vitamin D levels less than 74 nmol . L or 29 ng . ml Exclusion criteria:other concurrent diseases, including heart disease; Diabetes; Hepatitis; Hypo-parathyroid; Cardiac output less than 35%

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cardiac out put. Timepoint: Baseline andThree months later. Method of measurement: echocardiography.;Blood pressure. Timepoint: Baseline andThree months later. Method of measurement: Barometer.;Pulmonary hypertention. Timepoint: Baseline and quarterly. Method of measurement: echocardiography.;Ferittin level. Timepoint: Baseline andThree months later. Method of measurement: blood sample.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKiavash Fekri

Shahrekord University of Medical Sciences

k.fekri@skums.ac.ir+98 38332220016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026